Cargando…

Serial Measurements of Circulating KL-6, SP-D, MMP-7, CA19-9, CA-125, CCL18, and Periostin in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Therapy: An Exploratory Study

Idiopathic pulmonary fibrosis (IPF) is a progressive and inevitably fatal disease with a heterogeneous clinical course. This study aimed to evaluate the usefulness of circulating biomarkers in routine IPF clinical practice. We conducted an exploratory study in a cohort of 28 IPF subjects qualified f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Majewski, Sebastian, Szewczyk, Karolina, Żal, Aleksandra, Białas, Adam J., Miłkowska-Dymanowska, Joanna, Piotrowski, Wojciech J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432145/ https://www.ncbi.nlm.nih.gov/pubmed/34501312 http://dx.doi.org/10.3390/jcm10173864

Ejemplares similares

Epithelial Alarmins in Serum and Exhaled Breath in Patients with Idiopathic Pulmonary Fibrosis: A Prospective One-Year Follow-Up Cohort Study
por: Majewski, Sebastian, et al.
Publicado: (2019)

Longitudinal and Comparative Measures of Serum Chitotriosidase and YKL-40 in Patients With Idiopathic Pulmonary Fibrosis
por: Majewski, Sebastian, et al.
Publicado: (2022)

Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype
por: Miłkowska-Dymanowska, Joanna, et al.
Publicado: (2018)

Proteomic profiling of peripheral blood and bronchoalveolar lavage fluid in interstitial lung diseases: an explorative study
por: Majewski, Sebastian, et al.
Publicado: (2021)

The utility of telemedicine in managing patients after COVID-19
por: Bartczak, Krystian T., et al.
Publicado: (2022)

Calcium, Phosphate, and Vitamin D Status in Patients with Sarcoidosis—Associations with Disease Activity and Symptoms
por: Gwadera, Łukasz, et al.
Publicado: (2023)

The Role of Mitochondria and Oxidative/Antioxidative Imbalance in Pathobiology of Chronic Obstructive Pulmonary Disease
por: Białas, Adam Jerzy, et al.
Publicado: (2016)

Underrecognized comorbidities of chronic obstructive pulmonary disease
por: Miłkowska-Dymanowska, Joanna, et al.
Publicado: (2015)

Review: Serum Biomarkers of Lung Fibrosis in Interstitial Pneumonia with Autoimmune Features—What Do We Already Know?
por: Miądlikowska, Ewa, et al.
Publicado: (2021)

Serum KL-6, CA19-9, CA125 and CEA are Diagnostic Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease in the Chinese Population
por: Zheng, Muhan, et al.
Publicado: (2021)

CA-125 and CCL2 may indicate inflammation in peritoneal dialysis patients
por: de Oliveira, Wander Valadares, et al.
Publicado: (2021)

Geroprotectors as a therapeutic strategy for COPD – where are we now?
por: Miłkowska-Dymanowska, Joanna, et al.
Publicado: (2017)

Eosinopenia and neutrophil-to-lymphocyte count ratio as prognostic factors in exacerbation of COPD
por: Karauda, Tomasz, et al.
Publicado: (2021)

Study protocol for connective tissue disease-associated interstitial lung disease trial (TEL-CTD-ILD): A randomized controlled trial of a home-based telemonitoring of treatment effects
por: Małysiak-Szpond, Sylwia, et al.
Publicado: (2022)

Morphometric analysis of mitochondria in lymphocytes of patients with exacerbations of chronic obstructive pulmonary disease – pilot study
por: Białas, Adam J, et al.
Publicado: (2018)

Soluble ITGaM and ITGb2 Integrin Subunits Are Involved in Long-Term Pulmonary Complications after COVID-19 Infection
por: Siekacz, Kamil, et al.
Publicado: (2023)

Oxidative Biomarkers Associated with the Pulmonary Manifestation of Post-COVID-19 Complications
por: Siekacz, Kamil, et al.
Publicado: (2023)

Diagnostic value of pleural fluid SMRP, CA125, MMP-7, and MMP-9 in malignant pleural effusion
por: Han, Gaohua, et al.
Publicado: (2023)

Gender differences in health-related quality of life measured by the Sarcoidosis Health Questionnaire
por: Gwadera, Łukasz, et al.
Publicado: (2021)

Is Pulmonary Involvement a Distinct Phenotype of Post-COVID-19?
por: Bartczak, Krystian T., et al.
Publicado: (2023)

Chronotype and the Big-Five personality traits as predictors of chronic fatigue among patients with sarcoidosis. A cross-sectional study
por: Mokros, Łukasz, et al.
Publicado: (2023)

Serial KL-6 measurements in COVID-19 patients
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer
por: Dong, Dong, et al.
Publicado: (2018)

Oncological markers CA-125, CA 19-9 and endometriosis
por: Fiala, Ludek, et al.
Publicado: (2018)

Peritoneal trauma releases CA125?
por: Redman, C. W., et al.
Publicado: (1988)

Exploring the Glycosylation of Serum CA125
por: Saldova, Radka, et al.
Publicado: (2013)

CA125 effects on humoral immunosuppression
por: Kline, J. Bradford, et al.
Publicado: (2017)

Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis
por: Hamai, Kosuke, et al.
Publicado: (2016)

Mitochondrial functioning abnormalities observed in blood platelets of chronic smoke-exposed guinea pigs – a pilot study
por: Białas, Adam J, et al.
Publicado: (2018)

Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei
por: Liang, Lei, et al.
Publicado: (2021)

Massive Elevation of CA-125 in Chylous Ascites
por: Orbay, Tuğçe Merve, et al.
Publicado: (2023)

CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125.
por: Canney, P. A., et al.
Publicado: (1985)

The Value of CA 125 and CA72-4 in Management of Patients with Epithelial Ovarian Cancer
por: Fayed, Salah T., et al.
Publicado: (1998)

The Clinical Significance of CEA, CA19–9, and CA125 in Management of Appendiceal Adenocarcinoma
por: Yousef, Abdelrahman, et al.
Publicado: (2023)

Mesothelin Binding to CA125/MUC16 Promotes Pancreatic Cancer Cell Motility and Invasion via MMP-7 Activation
por: Chen, Shih-Hsun, et al.
Publicado: (2013)

Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2018)

Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy
por: Sun, Zhipeng, et al.
Publicado: (2014)

A Panel of CA19-9, Ca125, and Ca15-3 as the Enhanced Test for the Differential Diagnosis of the Pancreatic Lesion
por: Hogendorf, Piotr, et al.
Publicado: (2017)

Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge
por: Zhao, Song, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_casm63htkfvfr16c4fp4ne5ig5